Here’s whether Thermo Fisher Scientific, Inc. (TMO) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Caution.
🟡
Caution
Positives: RSI 58 — healthy momentum range; strong 1-year return of +13.0%. Concerns: trading below the 200-day MA (long-term downtrend); below the 50-day MA (medium-term momentum negative); 50-day MA is falling (-0.15% over 10 days). Currently 27.1% off its 52-week high. Score: -2/7.
TMO is trading below its 200-day MA ($526.25) — a key warning sign the longer-term trend is under pressure. An RSI of 57.8 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +13.0% compares to +22.9% for SPY (trailed the market by 9.9%). The current 27.1% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.
$10,000 invested 1 year ago→ $11,300 today
vs. S&P 500 (SPY) — same period trailed market by 9.9%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✗Above 200-day MA ($526.25)
✗Above 50-day MA ($478.88)
✓RSI(14) neutral zone (30–70) — currently 57.8
✓Positive return (+13.0%)
!Within 10% of period high (−27.1%)
Period Range $469.34
$385.46$643.99
RSI (14) 57.8
0 · OversoldOverbought · 100
Key Metrics
Price$469.34
Period Return+13.0%
Period High$643.99
Period Low$385.46
Drawdown−27.1%
MA-50$478.88
MA-200$526.25
RSI (14)57.8
Avg Volume (30d)2.5M
vs. SPYtrailed by 9.9%
Return Rank#587 of 1246
Trend Signals
Price is below the 200-day moving average ($526.25)
Price is below the 50-day moving average ($478.88)